MiMedx Group, Inc. (MDXG)
3.24
-0.08
(-2.41%)
USD |
NASDAQ |
Nov 12, 16:00
3.235
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Free Cash Flow (Quarterly) : 3.598M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.598M |
| June 30, 2026 | -10.67M |
| March 31, 2026 | 1.237M |
| December 31, 2025 | 22.62M |
| September 30, 2025 | 29.14M |
| June 30, 2025 | 14.23M |
| March 31, 2025 | 4.893M |
| December 31, 2024 | 19.61M |
| September 30, 2024 | 19.74M |
| June 30, 2024 | 21.40M |
| March 31, 2024 | 3.733M |
| December 31, 2023 | 9.776M |
| September 30, 2023 | 12.14M |
| June 30, 2023 | 7.427M |
| March 31, 2023 | -4.725M |
| December 31, 2022 | -7.333M |
| September 30, 2022 | 0.585M |
| June 30, 2022 | -3.434M |
| March 31, 2022 | -10.40M |
| December 31, 2021 | -3.546M |
| September 30, 2021 | 5.72M |
| June 30, 2021 | 1.147M |
| March 31, 2021 | -8.773M |
| December 31, 2020 | -12.54M |
| September 30, 2020 | -5.328M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.583M |
| March 31, 2020 | -13.37M |
| December 31, 2019 | -23.92M |
| September 30, 2019 | -3.433M |
| June 30, 2019 | 1.80M |
| March 31, 2019 | -16.08M |
| December 31, 2018 | -0.43M |
| September 30, 2018 | 0.914M |
| June 30, 2018 | 18.22M |
| March 31, 2018 | 7.069M |
| December 31, 2017 | 19.61M |
| September 30, 2017 | 16.56M |
| June 30, 2017 | 11.70M |
| March 31, 2017 | 9.671M |
| December 31, 2016 | 15.46M |
| September 30, 2016 | 1.066M |
| June 30, 2016 | 5.292M |
| March 31, 2016 | -3.132M |
| December 31, 2015 | 2.448M |
| September 30, 2015 | 5.453M |
| June 30, 2015 | 1.566M |
| March 31, 2015 | 2.662M |
| December 31, 2014 | 7.440M |
| September 30, 2014 | 8.076M |
| June 30, 2014 | 0.3788M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 6.716M |
| Perspective Therapeutics, Inc. | -35.91M |
| ABVC BioPharma, Inc. | -0.4389M |
| Enovis Corp. | 34.99M |
| Edwards Lifesciences Corp. | 506.70M |